Benign prostatic hyperplasia
Conditions
Interventions
Electroacupuncture Group:"Four Sacral Points" electroacupuncture
Drug Group:Tamsulosin hydrochloride sustained-release capsule
Sponsors
Xiangshan Traditional Chinese Medicine Hospital Huangpu District Shanghai
Eligibility
Sex/Gender
Male
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Age >=50 years and =8; (4) Agree to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with urinary tract infection; (2) Patients who have had prostate surgery; (3) Patients with impaired renal function bladder neoplasms bladder neck sclerosis prostate cancer; (4) Patients with severe prostatic hyperplasia resulting in complete obstruction of the urinary tract; (5) Patients who have used drugs for the treatment of prostate in last 2 weeks; (6) Patients with severe primary diseases or allergies; (7) Patients who would use drugs that may affect the efficacy; (8) Patients are unwilling or unable to complete the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of Life;International Prostate Symptom Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| B-ultrasound of prostate;B-ultrasound of residual urine;TPSA;FPSA; | — |
Countries
China
Contacts
Public ContactZhang Mengyuan
Xiangshan Traditional Chinese Medicine Hospital Huangpu District Shanghai
Outcome results
None listed